Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01901393 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery
A Phase 4 study, sponsored by Cumberland Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT01901393 is a Phase 4 study that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 100 participants.
The verdict
NCT01901393, a Phase 4 study, has completed, sponsored by Cumberland Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy of intravenous ibuprofen compared to ketorolac for the treatment of postoperative pain as measured by patient pain intensity (Visual Analog Scale, VAS)
Interventions
- DRUG Ketorolac
- DRUG IV ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01901393
The ClinicalTrials.gov registry entry for NCT01901393 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cumberland Pharmaceuticals, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT01901393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01901393 about?
NCT01901393 is a clinical study titled "Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery". The purpose of this study is to assess the efficacy of intravenous ibuprofen compared to ketorolac for the treatment of postoperative pain as measured by patient pain intensity (Visual Analog Scale, VAS)
What is the current status of trial NCT01901393?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2013-07. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01901393?
The interventions under investigation include: Ketorolac (DRUG), IV ibuprofen (DRUG).
Who is sponsoring clinical trial NCT01901393?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.